Savillex, LLC has completed its acquisition of Entegris, Inc.’s Life Sciences Fluid Management business, the Eden Prairie, Minn.-based company announced. Entegris is based in Billerica, Mass. The acquired portfolio includes Aramus and PE bags, single-use assemblies and components used across discovery, clinical and commercial manufacturing. Financial terms were not disclosed.
Savillex, a supplier of high-purity fluid handling solutions for life science and laboratory applications, said the transaction expands its life sciences offerings with an enhanced portfolio of high-performance single-use solutions. The company also welcomes the acquired Life Sciences Fluid Management team and its technologies in high-purity fluid management.
According to Savillex, customers can expect expanded single-use solutions, additional technical expertise and enhanced capabilities for applications from early-stage research through commercial manufacturing. The company said the combined strengths are intended to help customers simplify increasingly complex bioprocessing workflows.
Eric Giesing, chief executive officer of Savillex, said the acquired business has built a strong reputation in high-purity single-use bioprocessing and that the Aramus product line is a natural fit with the company’s existing Savillex, Containment and Bioprocessing offerings. He said the acquisition expands the company’s portfolio and enables it to offer a broader range of innovative solutions to biopharmaceutical and pharmaceutical customers.
Chris Bedi, general manager of Fluid Management at Savillex, said the transaction creates an opportunity to bring a broader portfolio of fluid management solutions to pharmaceutical and biopharmaceutical customers worldwide. He said the acquired portfolio complements Savillex’s existing capabilities and that the combined business will continue to provide innovative solutions while expanding support across drug development.
Savillex said the acquisition advances its strategy of delivering industry-leading solutions for the life sciences market and that it remains committed to investing in innovation, quality and customer partnerships. EC M&A served as financial advisor and Sidley Austin LLP served as legal counsel to Savillex.